https://news.medxy.ai/zh/12-13-dihome-prognostic-biomarker/Medxy AIzh2026-10-21T07:28:57-07:0012,13-diHOME：心搏骤停后靶向体温管理中棕色脂肪激活与预后的潜在标志物 https://news.medxy.ai/ja/dihome-biomarker-outcomes/Medxy AIja2026-10-21T07:28:35-07:0012,13-diHOME高値は心停止後TTMにおける褐色脂肪組織活性化と良好転帰の指標となりうる https://news.medxy.ai/vi/dihome-cardiac-arrest-temperature-control/Medxy AIvi2026-10-21T07:28:11-07:0012,13-diHOME: Dấu ấn tiềm năng của hoạt hóa mô mỡ nâu và tiên lượng trong kiểm soát thân nhiệt sau ngừng tim https://news.medxy.ai/1213-dihome-levels-as-a-marker-of-brown-adipose-tissue-activation-and-outcome-in-targeted-temperature-management-post-cardiac-arrest/Medxy AIen2026-10-21T07:27:47-07:0012,13-diHOME Levels as a Marker of Brown Adipose Tissue Activation and Outcome in Targeted Temperature Management Post-Cardiac Arrest https://news.medxy.ai/zh/encircle-tmvr-outcomes/Medxy AIzh2026-10-21T07:27:10-07:00SAPIEN M3 经房间隔 TMVR：ENCIRCLE MAC 注册研究二尖瓣瓣环钙化患者 1 年结局 https://news.medxy.ai/ja/transseptal-tmvr-mac-registry/Medxy AIja2026-10-21T07:26:48-07:00SAPIEN M3システムによる経中隔TMVR：ENCIRCLE MAC Registryが示した僧帽弁輪石灰化患者の1年成績 https://news.medxy.ai/vi/one-year-outcomes-sapien-m3-transseptal-mitral-valve-replacement/Medxy AIvi2026-10-21T07:26:25-07:00Kết quả 1 năm của thay van hai lá qua vách liên nhĩ bằng hệ thống SAPIEN M3 ở bệnh nhân vôi hóa vòng van hai lá từ sổ đăng ký ENCIRCLE MAC https://news.medxy.ai/transseptal-tmvr-using-the-sapien-m3-system-1-year-outcomes-in-patients-with-mitral-annular-calcification-from-the-encircle-mac-registry/Medxy AIen2026-10-21T07:26:05-07:00Transseptal TMVR Using the SAPIEN M3 System: 1-Year Outcomes in Patients with Mitral Annular Calcification from the ENCIRCLE MAC Registry https://news.medxy.ai/zh/high-impact-activity-arthritis-risk/Medxy AIzh2026-10-21T07:25:30-07:00高冲击体力活动会影响髋、膝骨关节炎的关节置换风险吗？一项大规模纵向中介研究 https://news.medxy.ai/ja/high-impact-exercise-joint-replacement-risk/Medxy AIja2026-10-21T07:25:07-07:00股関節・膝OAにおける高衝撃運動と関節置換リスク：大規模縦断媒介分析 https://news.medxy.ai/vi/high-impact-activity-joint-replacement/Medxy AIvi2026-10-21T07:24:42-07:00Hoạt động thể chất cường độ tác động mạnh và nguy cơ thay khớp ở thoái hóa khớp háng, gối: một nghiên cứu dọc quy mô lớn về vai trò trung gian https://news.medxy.ai/high-impact-physical-activity-and-joint-replacement-risk-in-hip-and-knee-osteoarthritis-a-large-scale-longitudinal-mediation-study/Medxy AIen2026-10-21T07:24:21-07:00High-Impact Physical Activity and Joint Replacement Risk in Hip and Knee Osteoarthritis: A Large-Scale Longitudinal Mediation Study https://news.medxy.ai/zh/emergency-surgery-recovery/Medxy AIzh2026-10-21T07:23:44-07:00急诊腹部手术后，综合呼吸与功能训练可促进撤机并加速恢复：来自随机对照试验的启示 https://news.medxy.ai/ja/accelerated-recovery-training/Medxy AIja2026-10-21T07:23:25-07:00呼吸・機能訓練の統合で離脱と回復を加速：緊急開腹手術RCTからの示唆 https://news.medxy.ai/vi/respiratory-training-ventilator-weaning/Medxy AIvi2026-10-21T07:23:02-07:00Kết hợp huấn luyện hô hấp và chức năng giúp tăng tỷ lệ cai máy thở và phục hồi sau phẫu thuật bụng cấp cứu: Góc nhìn từ một thử nghiệm đối chứng ngẫu nhiên https://news.medxy.ai/integrated-respiratory-and-functional-training-enhances-weaning-and-recovery-after-emergency-abdominal-surgery-insights-from-a-randomized-controlled-trial/Medxy AIen2026-10-21T07:22:43-07:00Integrated Respiratory and Functional Training Enhances Weaning and Recovery After Emergency Abdominal Surgery: Insights from a Randomized Controlled Trial https://news.medxy.ai/zh/peri-implant-soft-tissue-enhancement/Medxy AIzh2026-10-21T07:22:05-07:00优化种植体周围软组织维度：骨嵴软组织增量的时机与材料选择 https://news.medxy.ai/ja/optimizing-implant-tissue-enhancement/Medxy AIja2026-10-21T07:21:41-07:00歯槽頂部軟組織増大の最適化：インプラント周囲組織を高める時期と材料 https://news.medxy.ai/vi/implant-soft-tissue-augmentation/Medxy AIvi2026-10-21T07:21:14-07:00Tối ưu hóa kích thước mô quanh implant: Thời điểm và vật liệu trong tăng cường mô mềm vùng mào https://news.medxy.ai/optimizing-peri-implant-tissue-dimensions-timing-and-materials-in-crestal-soft-tissue-augmentation/Medxy AIen2026-10-21T07:20:54-07:00Optimizing Peri-Implant Tissue Dimensions: Timing and Materials in Crestal Soft-Tissue Augmentation https://news.medxy.ai/zh/ponatinib-blinatumomab-vs-imatinib-chemo/Medxy AIzh2026-10-21T07:20:17-07:00Ponatinib 联合 Blinatumomab 对比 Imatinib 联合化疗：推进成人 Philadelphia 染色体阳性 ALL 的一线治疗 https://news.medxy.ai/ja/ponatinib-blinatumomab-vs-imatinib-chemotherapy/Medxy AIja2026-10-21T07:19:56-07:00ponatinib＋blinatumomabはimatinib＋化学療法を上回るのか――成人Ph陽性ALLの一次治療を変える第3相試験 https://news.medxy.ai/vi/ponatinib-blinatumomab-all-treatment/Medxy AIvi2026-10-21T07:19:33-07:00Ponatinib phối hợp Blinatumomab so với Imatinib và Hóa trị: Bước tiến trong điều trị tuyến đầu ALL dương tính với Philadelphia ở người lớn https://news.medxy.ai/ponatinib-plus-blinatumomab-vs-imatinib-and-chemotherapy-advancing-frontline-therapy-in-adult-philadelphia-positive-all/Medxy AIen2026-10-21T07:19:13-07:00Ponatinib Plus Blinatumomab vs. Imatinib And Chemotherapy: Advancing Frontline Therapy in Adult Philadelphia-Positive ALL https://news.medxy.ai/zh/explainable-ai-oct-outcome-prediction/Medxy AIzh2026-10-21T07:15:41-07:00用可解释AI驱动的OCT生物标志物预测中心性浆液性脉络膜视网膜病变结局：来自多中心队列研究的启示 https://news.medxy.ai/ja/interpretable-ai-retinopathy-prognosis/Medxy AIja2026-10-21T07:15:24-07:00解釈可能AIで読み解く中心性漿液性脈絡網膜症の予後予測：多施設コホート研究からの知見 https://news.medxy.ai/vi/central-serous-retinopathy-prediction/Medxy AIvi2026-10-21T07:15:01-07:00Dự đoán diễn tiến bệnh lý hắc võng mạc trung tâm thanh dịch bằng AI có khả năng diễn giải từ biomarker OCT: Kết quả từ một nghiên cứu đoàn hệ đa trung tâm https://news.medxy.ai/predicting-central-serous-chorioretinopathy-outcomes-using-interpretable-ai-driven-oct-biomarkers-insights-from-a-multicenter-cohort-study/Medxy AIen2026-10-21T07:14:43-07:00Predicting Central Serous Chorioretinopathy Outcomes Using Interpretable AI-Driven OCT Biomarkers: Insights from a Multicenter Cohort Study https://news.medxy.ai/zh/facial-synkinesis-phenotypes/Medxy AIzh2026-10-21T07:14:03-07:00面部联动异常静息期表型分层：对手术规划的启示 https://news.medxy.ai/ja/facial-synkinesis-phenotype/Medxy AIja2026-10-21T07:13:44-07:00顔面連合運動の静止時表現型を読み解く：外科計画への示唆 https://news.medxy.ai/vi/resting-facial-synergies/Medxy AIvi2026-10-21T07:13:15-07:00Ba kiểu hình đồng vận mặt lúc nghỉ: Gợi ý quan trọng cho lập kế hoạch phẫu thuật https://news.medxy.ai/phenotypic-stratification-of-facial-synkinesis-resting-states-implications-for-surgical-planning/Medxy AIen2026-10-21T07:13:00-07:00Phenotypic Stratification of Facial Synkinesis Resting States: Implications for Surgical Planning https://news.medxy.ai/zh/acute-normovolemic-hemodilution-safety/Medxy AIzh2026-10-21T07:12:20-07:00女性心脏手术中急性等容性稀释的效果与安全性：血液保护策略是否仍需调整？ https://news.medxy.ai/ja/reassessing-acute-normovolemic-hemodilution/Medxy AIja2026-10-21T07:12:03-07:00女性の心臓手術における急性等容量血液希釈を再検証：有効性・安全性・臨床的意義 https://news.medxy.ai/vi/acute-isovolemic-hemodilution-heart-surgery/Medxy AIvi2026-10-21T07:11:40-07:00Trích máu pha loãng đẳng tích cấp tính ở phụ nữ phẫu thuật tim: Hiệu quả, độ an toàn và ý nghĩa lâm sàng https://news.medxy.ai/evaluating-acute-normovolemic-hemodilution-in-women-undergoing-cardiac-surgery-efficacy-safety-and-clinical-implications/Medxy AIen2026-10-21T07:11:23-07:00Evaluating Acute Normovolemic Hemodilution in Women Undergoing Cardiac Surgery: Efficacy, Safety, and Clinical Implications https://news.medxy.ai/zh/postpartum-blood-pressure-monitoring/Medxy AIzh2026-10-21T07:10:46-07:00产后 6 周血压监测：可预测妊娠期高血压女性的长期心血管风险 https://news.medxy.ai/ja/postpartum-blood-pressure-monitoring-3/Medxy AIja2026-10-21T07:10:26-07:00妊娠高血圧性疾患後の産後血圧モニタリングが将来の心血管リスクを予測する https://news.medxy.ai/vi/postpartum-blood-pressure-monitoring-2/Medxy AIvi2026-10-21T07:10:06-07:00Theo dõi huyết áp sau sinh ở phụ nữ có rối loạn tăng huyết áp thai kỳ dự báo nguy cơ tim mạch lâu dài https://news.medxy.ai/postpartum-blood-pressure-monitoring-after-hypertensive-disorders-of-pregnancy-predicts-long-term-cardiovascular-risk/Medxy AIen2026-10-21T07:09:47-07:00Postpartum Blood Pressure Monitoring After Hypertensive Disorders of Pregnancy Predicts Long-Term Cardiovascular Risk https://news.medxy.ai/zh/saroglitazar-pcos-masld-hope/Medxy AIzh2026-10-21T07:09:09-07:00Saroglitazar为PCOS合并MASLD女性的肝脂肪变性治疗带来新希望：一项多中心试验的启示 https://news.medxy.ai/ja/saroglitazar-pcos-liver-fat/Medxy AIja2026-10-21T07:08:46-07:00PCOS合併MASLD女性の肝脂肪化にSaroglitazarが有望：多施設共同試験からの知見 https://news.medxy.ai/vi/saroglitazar-pcos-masld-trial/Medxy AIvi2026-10-21T07:08:26-07:00Saroglitazar cho thấy triển vọng trong điều trị gan nhiễm mỡ ở phụ nữ mắc PCOS và MASLD: Góc nhìn từ một thử nghiệm đa trung tâm https://news.medxy.ai/saroglitazar-shows-promise-in-treating-hepatic-steatosis-in-women-with-pcos-and-masld-insights-from-a-multicenter-trial/Medxy AIen2026-10-21T07:08:10-07:00Saroglitazar Shows Promise in Treating Hepatic Steatosis in Women with PCOS and MASLD: Insights from a Multicenter Trial https://news.medxy.ai/zh/infections-alzheimers-neuropathologyorrelation/Medxy AIzh2026-10-21T07:07:33-07:00常见感染与阿尔茨海默病神经病理之间有何关联？——来自英国前瞻性队列研究的启示 https://news.medxy.ai/ja/common-infections-alzheimers-link/Medxy AIja2026-10-21T07:07:14-07:00一般的感染症とアルツハイマー病神経病理の関連を探る：英国前向きコホート研究からの知見 https://news.medxy.ai/vi/common-infections-alzheimers-link-2/Medxy AIvi2026-10-21T07:06:51-07:00Khám phá mối liên hệ giữa các nhiễm trùng thường gặp và bệnh lý thần kinh Alzheimer: Góc nhìn từ một nghiên cứu đoàn hệ tiến cứu tại Vương quốc Anh https://news.medxy.ai/infections-alzheimers-link/Medxy AIen2026-10-21T07:05:28-07:00Exploring the Link Between Common Infections and Alzheimer’s Disease Neuropathology: Insights From a UK Prospective Cohort Study https://news.medxy.ai/ja/heart-failure-definition-2026-3/Medxy AIja2026-10-21T07:04:45-07:00心不全の「第2版国際定義」2026年版：AHA/ACC/ESC/WHFコンセンサスの主要変更点と臨床への示唆 https://news.medxy.ai/vi/aha-heart-failure-definition/Medxy AIvi2026-10-21T07:04:15-07:00“Định nghĩa quốc tế về suy tim – Phiên bản thứ 2” (năm 2026): Những thay đổi chính trong sự đồng thuận của AHA/ACC/ESC/WHF và ý nghĩa đối với thực hành lâm sàng https://news.medxy.ai/zh/heart-failure-definition-2026-2/Medxy AIzh2026-10-21T07:03:43-07:002026版心力衰竭第二次统一定义：AHA/ACC/ESC/WHF专家共识的关键变化与临床要点 https://news.medxy.ai/second-universal-definition-of-heart-failure-2026-key-changes-and-clinical-guidance-from-the-aha-acc-esc-whf-expert-consensus/Medxy AIen2026-10-21T07:03:08-07:00Second Universal Definition of Heart Failure (2026): Key Changes and Clinical Guidance from the AHA/ACC/ESC/WHF Expert Consensus https://news.medxy.ai/zh/msi-high-gastric-cancer-immunotherapy/Medxy AIzh2026-10-21T07:02:10-07:00MSI-high 胃癌与胃食管结合部腺癌新辅助 nivolumab 联合 ipilimumab 的长期疗效：来自 NEONIPIGA 2 期试验的启示 https://news.medxy.ai/ja/neoadjuvant-immunotherapy-gastric-cancer/Medxy AIja2026-10-21T07:01:49-07:00MSI-high胃・胃食道接合部腺癌に対するニボルマブ／イピリムマブ術前療法の長期成績：第2相NEONIPIGA試験からの知見 https://news.medxy.ai/vi/long-term-outcomes-immunotherapy-gastric-cancer/Medxy AIvi2026-10-21T07:01:27-07:00Kết cục dài hạn của nivolumab và ipilimumab trước phẫu thuật trong ung thư biểu mô tuyến dạ dày và GEJ MSI-high: Góc nhìn từ thử nghiệm pha 2 NEONIPIGA https://news.medxy.ai/long-term-outcomes-of-neoadjuvant-nivolumab-and-ipilimumab-in-msi-high-gastric-and-gej-adenocarcinoma-insights-from-the-phase-2-neonipiga-trial/Medxy AIen2026-10-21T07:01:10-07:00Long-term Outcomes of Neoadjuvant Nivolumab and Ipilimumab in MSI-High Gastric and GEJ Adenocarcinoma: Insights from the Phase 2 NEONIPIGA Trial https://news.medxy.ai/zh/alignment-changes-after-acl-reconstruction/Medxy AIzh2026-10-21T07:00:27-07:00接近骨骼成熟期经骨骺前交叉韧带重建后的力线变化：PLUTO研究组的观察 https://news.medxy.ai/ja/alignment-changes-after-acl-reconstruction-3/Medxy AIja2026-10-21T07:00:06-07:00骨成熟直前の経骨端線ACL再建術後に生じるアライメント変化をどう捉えるか——PLUTO Study Groupの知見 https://news.medxy.ai/vi/alignment-changes-after-acl-reconstruction-2/Medxy AIvi2026-10-21T06:59:43-07:00Thay đổi thẳng trục sau tái tạo dây chằng chéo trước xuyên sụn tăng trưởng gần trưởng thành xương: Kinh nghiệm từ nhóm nghiên cứu PLUTO https://news.medxy.ai/navigating-alignment-changes-after-transphyseal-acl-reconstruction-near-skeletal-maturity-insights-from-the-pluto-study-group/Medxy AIen2026-10-21T06:59:25-07:00Navigating Alignment Changes After Transphyseal ACL Reconstruction Near Skeletal Maturity: Insights from the PLUTO Study Group https://news.medxy.ai/zh/pilates-fibromyalgia-rehabilitation/Medxy AIzh2026-10-21T06:58:49-07:00普拉提联合自我筋膜放松：6个月远程监督康复为纤维肌痛管理带来新思路 https://news.medxy.ai/ja/fibromyalgia-management/Medxy AIja2026-10-21T06:58:28-07:00ピラティスと自己筋膜リリースを組み合わせた6か月監督下テレリハビリテーションによる線維筋痛症管理の改善 https://news.medxy.ai/enhanced-fibromyalgia-management-through-six-month-supervised-telerehabilitation-integrating-pilates-and-self-myofascial-release/Medxy AIen2026-10-21T06:57:50-07:00Enhanced Fibromyalgia Management Through Six-Month Supervised Telerehabilitation: Integrating Pilates and Self-Myofascial Release https://news.medxy.ai/digitally-guided-root-membrane-preparation-using-a-dedicated-apex-guide-for-immediate-implant-placement-a-retrospective-case-series/Medxy AIen2026-10-21T06:57:17-07:00Digitally Guided Root Membrane Preparation Using a Dedicated Apex Guide for Immediate Implant Placement: A Retrospective Case Series https://news.medxy.ai/zh/shortened-hepatitis-c-treatment/Medxy AIzh2026-10-21T06:56:39-07:00慢性丙型肝炎无肝硬化患者的索磷布韦/维帕他韦疗程缩短：来自印度 RESOLVE 试验的证据 https://news.medxy.ai/ja/short-course-hepatitis-c-treatment/Medxy AIja2026-10-21T06:56:20-07:00非肝硬変慢性C型肝炎におけるソホスブビル・ベルパタスビル短期治療：インドRESOLVE試験のエビデンス https://news.medxy.ai/vi/shortened-sofosbuvir-velpatasvir-treatment/Medxy AIvi2026-10-21T06:56:01-07:00Rút ngắn điều trị Sofosbuvir-Velpatasvir cho viêm gan C mạn tính không xơ gan: Bằng chứng từ thử nghiệm RESOLVE tại Ấn Độ https://news.medxy.ai/shortening-sofosbuvir-velpatasvir-therapy-for-non-cirrhotic-chronic-hepatitis-c-evidence-from-the-resolve-trial-in-india/Medxy AIen2026-10-21T06:55:44-07:00Shortening Sofosbuvir-Velpatasvir Therapy for Non-Cirrhotic Chronic Hepatitis C: Evidence from the RESOLVE Trial in India https://news.medxy.ai/zh/pediatric-social-risk-screening/Medxy AIzh2026-10-21T06:55:06-07:00儿科住院社会风险筛查与转介实践现状：一项全国调查 https://news.medxy.ai/ja/social-risk-screening-referrals/Medxy AIja2026-10-21T06:54:52-07:00小児入院医療における社会的リスク・スクリーニングと紹介の実態：全国調査 https://news.medxy.ai/vi/social-risk-screening-referrals-2/Medxy AIvi2026-10-21T06:54:27-07:00Sàng lọc nguy cơ xã hội và thực hành chuyển tuyến trong nhi khoa nội trú: Kết quả từ một khảo sát quốc gia https://news.medxy.ai/assessing-social-risk-screening-and-referral-practices-in-pediatric-inpatient-care-a-national-survey/Medxy AIen2026-10-21T06:54:09-07:00Assessing Social Risk Screening and Referral Practices in Pediatric Inpatient Care: A National Survey https://news.medxy.ai/zh/neutrophil-lymphocyte-ratio-skin-cancer/Medxy AIzh2026-10-21T06:43:15-07:00高风险皮肤鳞状细胞癌中中性粒细胞/淋巴细胞比值的预后价值 https://news.medxy.ai/ja/neutrophil-lymphocyte-ratio/Medxy AIja2026-10-21T06:42:55-07:00高リスク皮膚扁平上皮癌における予後バイオマーカーとしての好中球/リンパ球比 https://news.medxy.ai/vi/neutrophil-lymphocyte-ratio-2/Medxy AIvi2026-10-21T06:42:34-07:00Tỷ lệ bạch cầu trung tính/bạch cầu lympho: dấu ấn tiên lượng trong ung thư biểu mô tế bào vảy da nguy cơ cao https://news.medxy.ai/neutrophil-to-lymphocyte-ratio-as-a-prognostic-biomarker-in-high-risk-cutaneous-squamous-cell-carcinoma/Medxy AIen2026-10-21T06:42:14-07:00Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in High-Risk Cutaneous Squamous Cell Carcinoma https://news.medxy.ai/zh/long-term-breast-reduction-lift-results/Medxy AIzh2026-10-21T06:41:35-07:00改良 Liacyr-Ribeiro 技术在乳房缩小与上提中的长期稳定效果 https://news.medxy.ai/ja/breast-reduction-lift-long-term-results/Medxy AIja2026-10-21T06:41:14-07:00乳房縮小・挙上術における改良Liacyr-Ribeiro法の長期的な安定した効果 https://news.medxy.ai/vi/long-term-breast-reduction-lift-results-2/Medxy AIvi2026-10-21T06:40:45-07:00Kết quả lâu dài bền vững của kỹ thuật Modified Liacyr-Ribeiro trong thu nhỏ tuyến vú và nâng tuyến vú https://news.medxy.ai/durable-long-term-outcomes-of-the-modified-liacyr-ribeiro-technique-in-breast-reduction-and-mastopexy/Medxy AIen2026-10-21T06:40:23-07:00Durable Long-Term Outcomes of the Modified Liacyr-Ribeiro Technique in Breast Reduction and Mastopexy https://news.medxy.ai/zh/ct-deep-learning-lung/Medxy AIzh2026-10-20T03:18:01-07:00CT深度学习助力间质性肺异常预后评估 https://news.medxy.ai/ja/chest-ct-deep-learning/Medxy AIja2026-10-20T03:17:43-07:00胸部CT深層学習が間質性肺異常の予後予測を強化 https://news.medxy.ai/vi/deep-learning-ct/Medxy AIvi2026-10-20T03:17:22-07:00Deep learning trên phim CT giúp cải thiện dự báo tiên lượng bất thường kẽ phổi https://news.medxy.ai/deep-learning-on-ct-scans-enhances-prognostication-of-interstitial-lung-abnormalities/Medxy AIen2026-10-20T03:17:04-07:00Deep Learning on CT Scans Enhances Prognostication of Interstitial Lung Abnormalities https://news.medxy.ai/zh/eye-metastasis-study/Medxy AIzh2026-10-20T03:16:23-07:0040年眼部转移瘤研究：569例患者的临床特征、生存结局与治疗效果 https://news.medxy.ai/ja/eye-metastasis-study-2/Medxy AIja2026-10-20T03:16:05-07:0040年にわたる眼転移の臨床像：569例にみる生存と治療成績 https://news.medxy.ai/vi/eye-metastasis-study-3/Medxy AIvi2026-10-20T03:15:44-07:00Bức tranh lâm sàng về di căn vào mắt trong suốt 40 năm: Tỷ lệ sống sót và kết quả điều trị qua 569 trường hợp https://news.medxy.ai/ocular-metastasis-over-four-decades-clinical-patterns-survival-and-therapeutic-outcomes-in-569-patients/Medxy AIen2026-10-20T03:15:26-07:00Ocular Metastasis Over Four Decades: Clinical Patterns, Survival, and Therapeutic Outcomes in 569 Patients https://news.medxy.ai/zh/hpv-nasopharyngeal-carcinoma/Medxy AIzh2026-10-20T03:14:41-07:00HPV 阳性与角化性鼻咽癌：预后意义及临床启示 https://news.medxy.ai/ja/hpv-positive-nasopharyngeal-carcinoma/Medxy AIja2026-10-20T03:14:24-07:00角化型鼻咽頭癌におけるHPV陽性の意義：予後予測と臨床応用への示唆 https://news.medxy.ai/vi/hpv-positive-nasopharyngeal-carcinoma-2/Medxy AIvi2026-10-20T03:14:02-07:00HPV dương tính trong ung thư biểu mô vòm mũi họng sừng hóa: Ý nghĩa đối với tiên lượng và thực hành lâm sàng https://news.medxy.ai/hpv-positivity-in-keratinizing-nasopharyngeal-carcinoma-implications-for-prognosis-and-clinical-practice/Medxy AIen2026-10-20T03:13:44-07:00HPV Positivity in Keratinizing Nasopharyngeal Carcinoma: Implications for Prognosis and Clinical Practice https://news.medxy.ai/zh/social-determinants-colon-cancer/Medxy AIzh2026-10-20T03:12:58-07:00患者层面社会决定因素对结肠癌结局的影响：综合医疗网络中的新型预后指标 https://news.medxy.ai/ja/colorectal-cancer-outcomes/Medxy AIja2026-10-20T03:12:37-07:00大腸癌転帰に対する患者レベルの社会的決定要因の影響：統合医療ネットワークにおける新規予後指標 https://news.medxy.ai/vi/social-determinants-cancer/Medxy AIvi2026-10-20T03:12:17-07:00Yếu tố quyết định xã hội ở cấp độ bệnh nhân và kết cục ung thư đại tràng: một chỉ số tiên lượng mới trong mạng lưới y tế tích hợp https://news.medxy.ai/impact-of-patient-level-social-determinants-on-colon-cancer-outcomes-a-novel-prognostic-measure-within-an-integrated-health-network/Medxy AIen2026-10-20T03:11:59-07:00Impact of Patient-Level Social Determinants on Colon Cancer Outcomes: A Novel Prognostic Measure Within an Integrated Health Network https://news.medxy.ai/zh/metformin-progestin-therapy/Medxy AIzh2026-10-20T03:11:24-07:00二甲双胍联合孕激素用于子宫内膜肿瘤保留生育治疗：FELICIA 试验带来的启示 https://news.medxy.ai/ja/fertility-preservation-metformin/Medxy AIja2026-10-20T03:11:03-07:00子宮内膜腫瘍の妊孕性温存治療におけるメトホルミン併用の意義：FELICIA試験からの知見 https://news.medxy.ai/vi/metformin-progestin-fertility/Medxy AIvi2026-10-20T03:10:43-07:00Metformin hỗ trợ cùng progestin trong điều trị bảo tồn khả năng sinh sản cho tân sinh nội mạc tử cung: Góc nhìn từ thử nghiệm FELICIA https://news.medxy.ai/adjunctive-metformin-with-progestin-in-fertility-sparing-treatment-of-endometrial-neoplasia-insights-from-the-felicia-trial/Medxy AIen2026-10-20T03:10:25-07:00Adjunctive Metformin with Progestin in Fertility-Sparing Treatment of Endometrial Neoplasia: Insights from the FELICIA Trial https://news.medxy.ai/ja/legalized-sports-betting-health/Medxy AIja2026-10-20T02:39:44-07:00オンラインスポーツ賭博の合法化が精神保健医療利用に及ぼす影響 https://news.medxy.ai/vi/legal-sports-betting-behavioral-health/Medxy AIvi2026-10-20T02:39:18-07:00Hợp pháp hóa cá cược thể thao trực tuyến và việc sử dụng dịch vụ sức khỏe hành vi https://news.medxy.ai/online-sports-betting-legalization-and-behavioral-health-care-use/Medxy AIen2026-10-20T02:38:58-07:00Online Sports Betting Legalization and Behavioral Health Care Use https://news.medxy.ai/zh/ontario-icu-family-survey/Medxy AIzh2026-10-20T02:38:20-07:00安大略省 ICU 推行全省网络家属满意度调查：一项质量改进实践的启示 https://news.medxy.ai/ja/icu-family-satisfaction-survey/Medxy AIja2026-10-20T02:37:55-07:00オンタリオ州のICUで家族満足度を可視化：Web調査導入が示した質改善の示唆 https://news.medxy.ai/vi/implementing-a-provincial-web-based-family-satisfaction-survey-in-icus/Medxy AIvi2026-10-20T02:37:30-07:00Trực quan hóa mức độ hài lòng của gia đình tại các đơn vị chăm sóc đặc biệt (ICU) ở tỉnh Ontario: Những gợi ý về cải thiện chất lượng từ việc triển khai khảo sát trực tuyến https://news.medxy.ai/implementing-a-provincial-web-based-family-satisfaction-survey-in-icus-insights-from-ontarios-quality-improvement-initiative/Medxy AIen2026-10-20T02:37:05-07:00Implementing a Provincial Web-Based Family Satisfaction Survey in ICUs: Insights from Ontario’s Quality Improvement Initiative https://news.medxy.ai/zh/pulmonary-embolism-management-in-outpatient/Medxy AIzh2026-10-20T02:36:27-07:00如何推广急性低危肺栓塞的门诊管理：证据、实施与未来展望 https://news.medxy.ai/ja/outpatient-pulmonary-embolism-management/Medxy AIja2026-10-20T02:36:03-07:00急性低リスク肺塞栓症の外来管理をどう広げるか：エビデンス、実装、今後の展望 https://news.medxy.ai/vi/outpatient-pulmonary-embolism-care/Medxy AIvi2026-10-20T02:35:35-07:00Mở rộng điều trị ngoại trú cho thuyên tắc phổi cấp nguy cơ thấp: bằng chứng, triển khai và định hướng tương lai https://news.medxy.ai/adoption-of-outpatient-management-of-acute-low-risk-pulmonary-embolism-evidence-implementation-and-future-directions/Medxy AIen2026-10-20T02:35:04-07:00Adoption of Outpatient Management of Acute Low-Risk Pulmonary Embolism: Evidence, Implementation, and Future Directions https://news.medxy.ai/zh/low-breast-cancer-screening-rates/Medxy AIzh2026-10-20T02:34:09-07:00学术型基层医疗中住院医师乳腺癌筛查率偏低：差距如何缩小？ https://news.medxy.ai/ja/low-resident-breast-screening/Medxy AIja2026-10-20T02:33:45-07:00学術的プライマリケアにおける研修医の乳がん検診率の低さ：その格差をどう埋めるか https://news.medxy.ai/vi/narrowing-screening-gap/Medxy AIvi2026-10-20T02:33:17-07:00Thu hẹp khoảng cách: Giải quyết tỷ lệ tầm soát ung thư vú thấp ở bác sĩ nội trú trong chăm sóc ban đầu học thuật https://news.medxy.ai/ja/quantitative-ct-pulmonary-fibrosis/Medxy AIja2026-10-20T02:31:41-07:00進行性肺線維症における定量的CT：INBUILD試験サブスタディから得られた知見 https://news.medxy.ai/apoe-alleles-cognition-in-aging/Medxy AIen2026-10-20T02:31:39-07:00Impact of APOE ɛ4 and ɛ2 Alleles on Cognitive Trajectories in Nonagenarians and Beyond: Insights from the LifeAfter90 Study https://news.medxy.ai/vi/quantitative-ct-progressive-pulmonary-fibrosis/Medxy AIvi2026-10-20T02:31:19-07:00Chụp cắt lớp vi tính định lượng trong xơ phổi tiến triển: Những hiểu biết từ phân tích phụ của thử nghiệm INBUILD https://news.medxy.ai/zh/uveal-melanoma-gep-prame-prognosis/Medxy AIzh2026-10-20T02:30:22-07:00葡萄膜黑色素瘤的15-GEP/PRAME检测预后价值：有无确认性细胞病理学的比较 https://news.medxy.ai/ja/uveal-melanoma-gep-prame-test/Medxy AIja2026-10-20T02:29:55-07:00ぶどう膜黒色腫における15-GEP/PRAME検査の予後的価値：確認細胞病理の有無による差異を検討した Collaborative Ocular Oncology Group Study 2 からの知見 https://news.medxy.ai/vi/prognostic-value-in-uveal-melanoma/Medxy AIvi2026-10-20T02:29:27-07:00Giá trị tiên lượng của xét nghiệm 15-GEP/PRAME có hoặc không có tế bào học xác nhận trong u hắc tố màng bồ đào: Kết quả từ nghiên cứu Collaborative Ocular Oncology Group Study 2 https://news.medxy.ai/prognostic-value-of-15-gep-prame-assay-with-or-without-confirmatory-cytopathology-in-uveal-melanoma-insights-from-the-collaborative-ocular-oncology-group-study-2/Medxy AIen2026-10-20T02:29:04-07:00Prognostic Value of 15-GEP/PRAME Assay With or Without Confirmatory Cytopathology in Uveal Melanoma: Insights From the Collaborative Ocular Oncology Group Study 2 https://news.medxy.ai/zh/cannabis-opioid-use-2/Medxy AIzh2026-10-20T02:28:23-07:00大麻使用与头颈部游离皮瓣重建术后阿片类药物使用延长：临床证据综述 https://news.medxy.ai/ja/cannabis-opioid-use/Medxy AIja2026-10-20T02:28:01-07:00頭頸部遊離皮弁再建後の大麻使用とオピオイド長期使用：臨床エビデンスの統合 https://news.medxy.ai/vi/cannabis-opioid-use-after-surgery/Medxy AIvi2026-10-20T02:27:34-07:00Sử dụng cannabis và tình trạng dùng opioid kéo dài sau phẫu thuật tái tạo vạt tự do vùng đầu và cổ: Tổng hợp bằng chứng lâm sàng https://news.medxy.ai/cannabis-use-and-prolonged-opioid-utilization-after-head-and-neck-free-flap-reconstructive-surgery-a-clinical-evidence-synthesis/Medxy AIen2026-10-20T02:27:09-07:00Cannabis Use and Prolonged Opioid Utilization After Head and Neck Free Flap Reconstructive Surgery: A Clinical Evidence Synthesis https://news.medxy.ai/zh/academic-surgery-dei-policy/Medxy AIzh2026-10-20T02:26:25-07:00学术外科如何应对反DEI联邦政策：在多元、科研与公平之间寻求平衡 https://news.medxy.ai/ja/academic-surgery-for-dei-policy/Medxy AIja2026-10-20T02:26:02-07:00学術外科はいかにしてDEIに反対する連邦政策に対応すべきか――多様性、科学研究、公平性の間でのバランスの模索 https://news.medxy.ai/vi/anti-dei-federal-policies-in-academic-surgery/Medxy AIvi2026-10-20T02:25:35-07:00Cách thức ngành phẫu thuật trong môi trường học thuật ứng phó với các chính sách liên bang chống lại DEI (Đa dạng, Công bằng và Hòa nhập): Tìm kiếm sự cân bằng giữa đa dạng, nghiên cứu và công bằng https://news.medxy.ai/navigating-anti-dei-federal-policies-in-academic-surgery-strategies-to-sustain-diversity-research-and-equity/Medxy AIen2026-10-20T02:25:14-07:00Navigating Anti-DEI Federal Policies in Academic Surgery: Strategies to Sustain Diversity, Research, and Equity https://news.medxy.ai/zh/molecular-map-of-term-labor/Medxy AIzh2026-10-20T02:24:39-07:00解析足月分娩的分子图谱：宫颈扩张不同阶段的研究见解 https://news.medxy.ai/ja/decoding-labor-molecular-map/Medxy AIja2026-10-20T02:24:15-07:00正期産分娩の分子地図を読み解く：子宮頸管拡張段階からみた知見 https://news.medxy.ai/vi/human-labor-insights-across-cervical-dilatation/Medxy AIvi2026-10-20T02:23:41-07:00Giải mã bối cảnh phân tử của quá trình chuyển dạ đủ tháng: Những hiểu biết từ các nghiên cứu về những giai đoạn khác nhau của quá trình giãn cổ tử cung https://news.medxy.ai/decoding-the-molecular-landscape-of-human-labor-insights-across-cervical-dilatation-at-term/Medxy AIen2026-10-20T02:23:17-07:00Decoding the Molecular Landscape of Human Labor: Insights Across Cervical Dilatation at Term https://news.medxy.ai/zh/reassessing-easl-2025-benefits/Medxy AIzh2026-10-20T02:22:35-07:00重新审视 EASL 2025 标准：核苷（酸）类似物在慢性乙型肝炎中超出当前推荐范围的获益 https://news.medxy.ai/ja/reassessing-easl-2025-guidelines/Medxy AIja2026-10-20T02:22:11-07:00EASL 2025基準の再考：慢性B型肝炎におけるヌクレオシ(t)ドアナログの、現行推奨を超えた意義 https://news.medxy.ai/vi/reassessing-easl-2025-criteria/Medxy AIvi2026-10-20T02:21:42-07:00Đánh giá lại tiêu chí EASL 2025: Lợi ích của chất tương tự nucleos(t)ide trong viêm gan B mạn tính vượt ngoài khuyến cáo hiện hành https://news.medxy.ai/reevaluating-easl-2025-criteria-benefits-of-nucleostide-analogues-in-chronic-hepatitis-b-beyond-current-recommendations/Medxy AIen2026-10-20T02:21:19-07:00Reevaluating EASL 2025 Criteria: Benefits of Nucleos(t)ide Analogues in Chronic Hepatitis B Beyond Current Recommendations https://news.medxy.ai/zh/global-dementia-incidence-review-meta/Medxy AIzh2026-10-20T02:20:39-07:00全球各类原因所致痴呆症的发病：全面荟萃分析与最新研究发现 https://news.medxy.ai/ja/global-dementia-incidence-review/Medxy AIja2026-10-20T02:20:13-07:00世界の全原因認知症発症：包括的メタアナリシスと最新知見 https://news.medxy.ai/vi/global-incidence-of-all-cause-dementia-a-comprehensive-meta-analysis/Medxy AIvi2026-10-20T02:19:38-07:00Sự khởi phát chứng sa sút trí tuệ do mọi nguyên nhân trên toàn cầu: Phân tích gộp toàn diện và các phát hiện mới nhất https://news.medxy.ai/global-incidence-of-all-cause-dementia-a-comprehensive-meta-analysis-and-contemporary-insights/Medxy AIen2026-10-20T02:19:06-07:00Global Incidence of All-Cause Dementia: A Comprehensive Meta-Analysis and Contemporary Insights https://news.medxy.ai/zh/type-1-diabetes-mortality/Medxy AIzh2026-10-20T02:18:09-07:001型糖尿病的性别特异性死亡风险：近几十年先进治疗带来的启示 https://news.medxy.ai/ja/sex-differences-diabetes-mortality/Medxy AIja2026-10-20T02:17:47-07:001型糖尿病の死亡リスクにみられる性差：近年の先進医療が示す新たな知見 https://news.medxy.ai/vi/type-1-diabetes-mortality-risks/Medxy AIvi2026-10-20T02:17:20-07:00Đái tháo đường týp 1 và nguy cơ tử vong khác nhau theo giới: Góc nhìn từ nhiều thập kỷ điều trị hiện đại https://news.medxy.ai/sex-specific-mortality-risk-in-type-1-diabetes-insights-from-recent-decades-of-advanced-care/Medxy AIen2026-10-20T02:16:56-07:00Sex-Specific Mortality Risk in Type 1 Diabetes: Insights from Recent Decades of Advanced Care https://news.medxy.ai/zh/mitral-regurgitation-assessment-amyloid-cardiomyopathy/Medxy AIzh2026-10-20T02:16:19-07:00重新校准转甲状腺素蛋白淀粉样变性心肌病中的二尖瓣反流评估：一项多中心队列研究提升预后判别精度 https://news.medxy.ai/ja/mitral-regurgitation-amyloidosis/Medxy AIja2026-10-20T02:15:58-07:00トランスサイレチンアミロイド心筋症における僧帽弁逆流評価の再構築：多施設コホート研究が予後予測精度を高める https://news.medxy.ai/vi/refining-mitral-regurgitation-assessment-in-ttcr/Medxy AIvi2026-10-20T02:15:25-07:00Điều chỉnh lại phương pháp đánh giá hở van hai lá trong bệnh cơ tim do lắng đọng amyloid transthyretin https://news.medxy.ai/refining-mitral-regurgitation-assessment-in-transthyretin-amyloid-cardiomyopathy-a-multicenter-cohort-study-enhances-prognostic-precision/Medxy AIen2026-10-20T02:15:02-07:00Refining Mitral Regurgitation Assessment in Transthyretin Amyloid Cardiomyopathy: A Multicenter Cohort Study Enhances Prognostic Precision https://news.medxy.ai/zh/neoadjuvant-stereotactic-ablative-radiotherapy/Medxy AIzh2026-10-20T02:14:22-07:00肾细胞癌下腔静脉血栓切除术前的立体定向放射消融治疗：一项新的II期临床证据综述 https://news.medxy.ai/ja/stereotactic-radiotherapy-renal-cancer/Medxy AIja2026-10-20T02:14:01-07:00腎細胞癌の下大静脈血栓摘除術前に行う定位放射線焼灼療法：新たな第2相エビデンスの総括 https://news.medxy.ai/vi/neoadjuvant-stereotactic-ablative-radiotherapy-prior-to-inferior-vena-cava-thrombectomy/Medxy AIvi2026-10-20T02:13:32-07:00Xạ trị định vị (SBRT) trước phẫu thuật lấy huyết khối tĩnh mạch chủ dưới ở bệnh nhân ung thư biểu mô tế bào thận: Tổng quan các bằng chứng mới từ nghiên cứu giai đoạn 2 https://news.medxy.ai/neoadjuvant-stereotactic-ablative-radiotherapy-prior-to-inferior-vena-cava-thrombectomy-in-renal-cell-carcinoma-a-synthesis-of-emerging-phase-2-evidence/Medxy AIen2026-10-20T02:13:08-07:00Neoadjuvant Stereotactic Ablative Radiotherapy Prior to Inferior Vena Cava Thrombectomy in Renal Cell Carcinoma: A Synthesis of Emerging Phase 2 Evidence https://news.medxy.ai/zh/swimming-health-education-low-back-pain/Medxy AIzh2026-10-20T02:12:19-07:00游泳联合健康教育：慢性下背痛管理的短期获益 https://news.medxy.ai/ja/swimming-plus-education-for-chronic-low-back-pain/Medxy AIja2026-10-20T02:11:56-07:00水泳と健康教育の併用：慢性腰痛管理における短期的な有益性 https://news.medxy.ai/vi/swimming-chronic-back-pain/Medxy AIvi2026-10-20T02:11:30-07:00Bơi lội kết hợp giáo dục: Lợi ích ngắn hạn trong kiểm soát đau thắt lưng mạn tính https://news.medxy.ai/swimming-plus-education-short-term-benefits-for-chronic-low-back-pain-management/Medxy AIen2026-10-20T02:11:09-07:00Swimming Plus Education: Short-Term Benefits for Chronic Low Back Pain Management https://news.medxy.ai/zh/patient-centered-rehabilitation-learning/Medxy AIzh2026-10-20T02:10:37-07:00借助以患者为中心的结局数据，推动康复照护升级与双向学习 https://news.medxy.ai/ja/patient-centered-rehabilitation-outcomes/Medxy AIja2026-10-20T02:10:15-07:00患者中心アウトカムデータを活かしたリハビリテーション医療の質向上と相互学習 https://news.medxy.ai/vi/patient-centered-rehabilitation-outcomes-2/Medxy AIvi2026-10-20T02:09:45-07:00Khai thác dữ liệu kết cục lấy người bệnh làm trung tâm để nâng cao chăm sóc phục hồi chức năng và học tập tương hỗ https://news.medxy.ai/harnessing-patient-centered-outcomes-data-for-enhanced-rehabilitation-care-and-reciprocal-learning/Medxy AIen2026-10-20T02:09:18-07:00Harnessing Patient-Centered Outcomes Data for Enhanced Rehabilitation Care and Reciprocal Learning https://news.medxy.ai/ja/intraoral-ultrasound-probing-depth/Medxy AIja2026-10-20T02:08:35-07:00口腔内超音波による頬側中央部プロービング深さ評価：概念実証の臨床的一致性研究 https://news.medxy.ai/vi/intraoral-ultrasound-periodontal-depth/Medxy AIvi2026-10-20T02:08:04-07:00Siêu âm trong miệng để đánh giá độ sâu thăm dò vùng giữa mặt ngoài: Nghiên cứu đồng thuận lâm sàng chứng minh khái niệm https://news.medxy.ai/intraoral-ultrasonography-for-mid-buccal-probing-depth-assessment-a-proof-of-concept-clinical-agreement-study/Medxy AIen2026-10-20T02:07:38-07:00Intraoral Ultrasonography for Mid-Buccal Probing Depth Assessment: A Proof-of-Concept Clinical Agreement Study https://news.medxy.ai/ja/icotrokinra-ulcerative-colitis-trial/Medxy AIja2026-10-20T02:06:59-07:00潰瘍性大腸炎に対するIcotrokinra第2相試験 https://news.medxy.ai/vi/oral-icotrokinra-colitis-trial/Medxy AIvi2026-10-20T02:06:31-07:00Icotrokinra đường uống trong viêm loét đại tràng: Kết quả đáng chú ý từ thử nghiệm pha 2 https://news.medxy.ai/phase-2-trial-of-icotrokinra-for-patients-with-ulcerative-colitis/Medxy AIen2026-10-20T02:06:13-07:00Phase 2 Trial of Icotrokinra for Patients with Ulcerative Colitis